Daniela Elise Tache Selected Research

dactolisib

1/2017	Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
1/2015	Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Elise Tache Research Topics

Disease

12	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 01/2014
10	Neoplasms (Cancer) 10/2023 - 03/2013
8	Glioma (Gliomas) 10/2023 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2014
2	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2014
1	Pathologic Processes 10/2023
1	Carcinogenesis 10/2023
1	Multiple Sclerosis 10/2023
1	Craniocerebral Trauma (Head Injury) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Medulloblastoma 01/2017
1	Meningioma (Meningiomas) 01/2014
1	Astrocytoma (Pilocytic Astrocytoma) 01/2014

Drug/Important Bio-Agent (IBA)

4	Epidermal Growth Factor (EGF)IBA 10/2023 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2015
3	alpha-latrotoxin receptorIBA 10/2023 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2015
2	LigandsIBA 10/2023 - 01/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023 - 01/2015
2	Temozolomide (Temodar)FDA LinkGeneric 07/2022 - 11/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022 - 11/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
2	Growth Factor ReceptorsIBA 09/2019 - 01/2015
2	Peptides (Polypeptides)IBA 01/2018 - 01/2014
2	SU 1498IBA 01/2017 - 01/2015
2	dactolisibIBA 01/2017 - 01/2015
1	Monoclonal AntibodiesIBA 10/2023
1	AntibodiesIBA 10/2023
1	Sorafenib (BAY 43-9006)FDA Link 04/2023
1	BromidesIBA 04/2023
1	Axitinib (AG 013736)IBA 04/2023
1	ferric oxide (iron oxide)IBA 07/2021
1	cytolysin III (Stoichactis helianthus)IBA 07/2021
1	Alkylating AgentsIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2019
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2013

Therapy/Procedure

7	Therapeutics 10/2023 - 05/2014
2	Immunotherapy 01/2018 - 01/2018
1	Combined Modality Therapy 01/2021
1	Radiotherapy 09/2019
1	Molecular Targeted Therapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2017